“I am very honored to present and discuss VistA modernization to HIT industry leaders, which is timely given recent news about further delays in commercial off-the-shelf EHR deployments at VA,” said Whitmer.

JUNO BEACH, Fla. (PRWEB)
May 18, 2023

Document Storage Systems, Inc. (DSS, Inc.), a leading provider of health information technology (HIT) solutions for federal, private and public health care organizations, today announced that it is presenting at The Spring 2023 DoD/VA & Government HIT Summit on May 24-25. DSS is also a platinum sponsor to this event in National Harbor, Md.

Titled, “VistA Modernization: An approach for evolution, not revolution,” this session will highlight how the modernization of Veteran Integrated Service Technology Architecture (VistA) and Computerized Patient Record System (CPRS) Electronic Health Record (EHR) are a necessity to ensure the safety and quality of patient care.

VistA is the existing comprehensive, full-featured Health Information System and Electronic Health Record. Its purpose is to better focus on patient care and clinician needs.

David Whitmer, FACHE and vice president for product operations (federal) at DSS, will present and lead this discussion on Thursday, May 25 at 10:45AM to 11:15AM.

“I am very honored to present and discuss VistA modernization to HIT industry leaders, which is timely given recent news about further delays in commercial off-the-shelf EHR deployments at VA,” said Whitmer. “By service enabling VistA in the Cloud, our Veterans don’t have to wait for over a decade to see the benefits of modernization. Modernization of VistA in an incremental, sustainable, and cost-effective manner is within reach and already taking place.”

Whitmer shared that DSS, and other industry partners must be ready to help VA achieve their HIT goals and honor the commitment to providing the best care anywhere.

David Whitmer is a board-certified health care executive with 30 years of public health experience, including 20 years in C-suite positions directing facilities and operations for the Veterans Health Administration (VHA) and the National Institutes of Health (NIH), along with 10 years as a member of the Senior Executive Service (SES).

About Document Storage Systems, Inc. (DSS, Inc.)

Document Storage Systems, Inc. (DSS) is a catalyst for health care innovation, keeping pace with evolving technologies as a solutions provider, systems integrator, and services contractor to the Department of Veterans Affairs. DSS is committed to assisting VA in its High Reliability Organization journey and delivering care quality for Veterans by meeting top initiatives, changing regulatory requirements, and implementing enhanced business transformation across VA enterprise. For more information, visit https://www.dssinc.com.

Share article on social media or email:

Middle School Science Teachers Participate in National STEM Scholar Program

“The National STEM Scholar Program is an excellent way for teachers to learn new strategies and new ways to engage students to help them become and stay interested in science and math.”

LOUISVILLE, Ky. (PRWEB)
May 18, 2023

Ten middle school teachers from eight states have been selected to participate in the prestigious National STEM Scholar Program, a unique professional development program providing advanced STEM (science, technology, engineering, and math) training, national network building and project support for middle school science teachers nationwide.

Created in partnership between the National Stem Cell Foundation and The Gatton Academy of Mathematics and Science at Western Kentucky University (WKU), the National STEM Scholar Program selects ten teachers each year from a national pool of applicants based solely on the description of a “big idea” Challenge Project the applicant would implement in their classroom if funds were available. Selected projects are chosen for maximum impact in middle school classrooms where research shows lifelong STEM career decisions are being made. STEM Scholars convene on WKU’s campus for a week of advanced STEM training and finalize their projects with input from their STEM Scholar class colleagues.

The 2023 National STEM Scholar class will be hosted by The Gatton Academy from May 29th to June 2nd on the campus of WKU in Bowling Green, KY:

• Laura Cummings, Haleiwa, HI – Sunset Beach Elementary School
• James “JJ” Frye, Leitchfield, KY – Grayson County Middle School
• Emily Harer, St. Paul, MN – Global Arts Plus – Upper Campus
• Erin Hullinger, Buxton, ME – Bonny Eagle Middle School
• Patricia “Pati” Huntington, San Diego, CA – Farb Middle School
• Jennifer “Jenny” McCall, Lexington, KY – Winburn Middle School
• Michele Mitnitsky, Sanibel, FL – The Sanibel School
• Teresa Robertson, Munfordville, KY – Munfordville Elementary School
• Sarah StCyr, Sulphur, LA – W.W. Lewis Middle School
• Kandice Taylor, Jackson, MS – Brinkley Middle School

Studies show that middle school students who become excited about science are the ones who will pursue STEM courses in high school and major in them at the technical and college level. At a pivotal time in decision-making that will open or close the door to opportunity, however, nearly 50% of 8th graders in America lose interest in pursuing the STEM-related subjects increasingly required for 21st-century jobs.

Dr. Paula Grisanti, CEO of the National Stem Cell Foundation, said, “we added education to our mission and partnered with The Gatton Academy in 2015 to support the development of a new generation of scientists in academic research, advanced technology, and infrastructure engineering. Supporting teachers who inspire and motivate middle school students at this critical decision-making age will directly impact how many choose to pursue the STEM skills essential for living wage jobs. By investing in the influential middle school STEM teacher now, we reach thousands of students in classrooms today and far into the future.”

Dr. Julia Link Roberts, Executive Director of The Gatton Academy, added, “this partnership will accrue benefits for the National STEM Scholars, middle school students in their classrooms, and the middle school science teachers with whom they collaborate. The National STEM Scholar Program is an excellent way for teachers to learn new strategies and new ways to engage students to help them become and stay interested in science and math.”

Now in its 8th year, there are 80 National STEM Scholars representing middle schools in 33 states. 91% teach in public schools, 41% teach in mid- to high-poverty schools and 38% teach in communities with a population under 15,000. A unique requirement of the program is the responsibility for STEM Scholars to share lessons learned with colleagues in their home schools, districts or states, magnifying impact over multiple classrooms and years. By June 2023, National STEM Scholars will have directly and indirectly impacted more than 104,000 middle school students in the U.S.

About the National Stem Cell Foundation

The National Stem Cell Foundation is a 501(c)3 non-profit organization that funds adult stem cell and regenerative medicine research, underwrites the National STEM Scholar Program for middle school science teachers inspiring the next generation of STEM pioneers nationwide, and covers copays and deductibles for children of limited means participating in clinical trials for rare diseases. For more information, visit http://www.nationalstemcellfoundation.org.

About The Gatton Academy

Established in 2007, The Gatton Academy is Kentucky’s first residential two-year program for gifted and talented juniors and seniors. The Gatton Academy’s students enroll as juniors and are full-time WKU students pursuing their interests in advanced science, technology, engineering, and mathematics. The Gatton Academy is a recipient of the 2022 Inspiring Programs in STEM Award from Insight Into Diversity Magazine and the Innovation Partnership Award from the National Consortium for Secondary STEM Schools.

Share article on social media or email:

The featured experts will also discuss the recent US Food and Drug Administration (FDA) guidance and share their vision on the future of Lupus research and opportunities to drive research forward.

TORONTO (PRWEB)
May 18, 2023

Systemic Lupus Erythematosus (SLE) clinical trials are complex and can be challenging to conduct. The use of multiple questionnaires, assessing the same symptoms, each with different scoring systems and criteria, can complicate data collection and analysis. But, with direct data capture technology and a fit-for-purpose Electronic Lupus Assessment Suite of tools, clinicians can streamline the data collection process and ensure SLE research is straightforward, efficient and reliable.

Learn from a panel of clinical experts at the forefront of Lupus research, explore traditional data collection challenges that can arise in Lupus clinical trials and hear first-hand experiences solving these challenges.

The featured experts will also discuss the recent US Food and Drug Administration (FDA) guidance and share their vision on the future of Lupus research and opportunities to drive research forward.

Join today and hear from clinical experts on how the Electronic Lupus Assessment Suite helps solve data collection challenges in Lupus clinical trials.

Join Rinah Yamamoto, Principal Scientist, Clinical Ink; Neil Solomons, Chief Medical Director, Aurinia Pharmaceuticals; and Ed Vital, Associate Professor in Systemic Lupus Erythematosus, University of Leeds & Chair of BILAG and the Lupus Forum, for the live webinar on Wednesday, June 7, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Solving Data Collection Challenges in Lupus Trials with the Electronic Lupus Assessment Suite.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Hamptons Medical Weight Loss Doctor – Logo

Our practice is one of very few New York board certified providers that offer compounded tirzepatide for medical weight loss, as the nationwide shortage of the medication has put a strain on its availability.

NEW YORK (PRWEB)
May 18, 2023

Medical director and founder of the Southampton, NY based Hamptons Medical Weight Loss Doctor, Dr. Sue Decotiis, announced today that her specialty medical weight loss practice has noted a surge in men and women seeking Mounjaro™ (also known by its generic sister name tirzepatide) one-weekly injectable peptide therapy for medical weight loss. Mounjaro™ is FDA-approved to treat overweight / obese individuals, as well as individuals affected by type 2 diabetes.

According to a study published in the New England Journal of Medicine: “With the use of the efficacy estimated at 40 weeks, greater reductions in the fasting serum glucose level were observed with all tirzepatide doses than with semaglutide. In addition, all the tirzepatide doses resulted in greater reductions than those with semaglutide in the patient-measured mean blood glucose levels at all seven time points”, meaning patients who received weekly tirzepatide injections and practiced healthy lifestyle choices were able to lose sufficient weight compared to those who underwent semaglutide injections, alternatively.

“Our practice is one of very few New York board certified providers that offer compounded tirzepatide for medical weight loss, as the nationwide shortage of the medication has put a strain on its availability,” the triple board certified medical weight loss specialist, Dr. Sue Decotiis observed. Patients with type 2 diabetes and obesity have a long history of managing their weight successfully with the help of the GLP-1 receptor agonist.

Due to widespread isolation brought on by the COVID-19 epidemic, an increase in people seeking Mounjaro® weight loss counseling can be attributed to this worldwide health crisis. Many Americans adopted a dramatic and prolonged inactive lifestyle. The National Institute of Health states that psychological distress, pre-pandemic weight status, having children at home, and the amount of time since the last bodyweight check were statistically significant predictors of pandemic weight gain.

About Us

The board certified Hamptons weight loss specialist doctor offers prescriptions for medical weight loss including Mounjaro, Ozempic, Semaglutide, and Tirzepatide. Peptide therapy for weight loss is also offered including AOD-9604 (Advanced Obesity Drug), CJC-1295 / Ipamorelin, and Tesofensine. Hamptons Medical Weight Loss Doctor, specializing in weight loss treatments, is spearheaded by the best in class triple board certified medical weight loss doctor, Sue Decotiis, MD.

Hamptons Medical Weight Loss Doctor frequently treat treats patients from South Hampton, Bridgehampton, East Hampton, Hampton Bays, Montauk, Sag Harbor, Watermill, Southampton, West Hampton, and Quogue.

Hamptons Medical Weight Loss Doctor

53 Hill Street

Suite 104

Southampton, NY 11968

(631) 910-7185

https://www.hamptonsmedicalweightlossdoctor.com

Share article on social media or email:

As we seek to digitally transform healthcare, we are continuously in pursuit of creating state-of-the-art technology that improves the experience of dental professionals and patients alike.

BOSTON (PRWEB)
May 18, 2023

Revolutionary innovation continues at Bola Technologies, Inc. (Bola AI), as the leading provider of voice technology for healthcare and dental professionals is set to become the first company to implement generative AI and LLMs into its dental patient charting notes solution. The solution is expected to become available later this year.

The generative AI addition to Bola’s Clinical Notes software is designed to help turn tedious tasks into simple, quick engagements through AI. It allows for a fast, accurate voice transcription, freeing up dentists, hygienists and front-office staff to better serve the needs of patients by alleviating hours previously spent on note-taking and patient charting.

“The future of speech artificial intelligence is here,” said Rushi Ganmukhi, founder and CEO of Bola AI. “As we seek to digitally transform healthcare, we are continuously in pursuit of creating state-of-the-art technology that improves the experience of dental professionals and patients alike. Adding human-in-the-loop AI capabilities to our software is the next step toward developing a truly touchless environment for dental practices. One of the most powerful aspects of AI is personalization, allowing providers to use their personal workflow on a general product.”

Dental health practices that leverage Bola AI’s Clinical Notes software can realize the following benefits:

• 
  Creating convenience and standardization in workflow.
• Enabling more quality time with patients.
• Eliminating the need to scribble notes between appointments.
• Dictating common workflows by working with PMs templates.
• Using standardized templates for insurance and documentation purposes.
• Alleviating work after hours by making note dictation quicker.

Clinical Notes — available now for use with any practice management software — works with or without Bola AI’s Voice Perio system, which enables dental staff to seamlessly record periodontal data directly into client PMs and EHR systems in real time. Clinical Notes is trained on dental vocabulary, improves its AI use over time and can be used with any desktop-based EHR.

“At Bola AI, our focus is to make time-consuming tasks easier and more efficient,” says Ganmukhi. “Introducing generative AI into our Clinical Notes software accomplishes those goals and helps practices drive additional revenue while reclaiming extra time in the process.”

Tap into the latest innovation and cutting-edge AI technology for your dental practice by partnering with Bola AI today.

About Bola AI

Bola AI is the leader in Voice AI software for the dental practice. By harnessing the power of advanced technologies, this platform can provide efficient, fully integrated and accurate speech (99%) solutions for periodontal charting, clinical notes and more. With Bola AI, practices can empower themselves to create a smarter patient experience while improving operational efficiency and driving revenue. Headquartered in Boston, MA, Bola AI partners with Dentrix and Dentrix Ascend, Curve, Patterson and more. For more information, visit bola.ai.

Share article on social media or email:

“Whether you are an institutional investor, a day trader looking to diversify your portfolio or a healthcare professional keeping tabs on the industry, our advanced biotech investing tools and resources will deliver significant value.”—says Kris Kagan, SVP, BioPharmCatalyst.

SAN DIEGO (PRWEB)
May 18, 2023

BioPharmCatalyst (BPC), a division of Scientist.com, announced today that it has expanded the suite of digital tools it provides biotech investors and other life science professionals. The company’s new Elite plan gives users access to BPC’s core services and a wide range of new features, including data on historical probabilities of clinical trial success, insider trading activities, mergers and acquisitions as well as a detailed biotech conference calendar. BPC now also provides data and analytics on private biotech companies not yet publicly traded. Larger users such as venture capitalists, growth equity investors and private equity investors can access most of this data through BPC’s new Application Programming Interface (API), allowing seamless integration of BPC’s rich data into their existing workflows.

“We’re excited to unveil BioPharmCatalyst Elite in addition to access to our API, which provides our subscriber base with a wealth of new site features and easy access for businesses that want to integrate our data into their everyday processes,” says Kris Kagan, SVP, BioPharmCatalyst. “Whether you are an institutional investor, a day trader looking to diversify your portfolio or a healthcare professional keeping tabs on the industry, our advanced biotech investing tools and resources will deliver significant value.”

BPC provides indispensable tools to anyone interested in investing in the biotech industry. It helps investors make well-informed decisions based on the most recent corporate updates and clinical trial results. The newly released API facilitates real-time data retrieval from various endpoints, such as the FDA calendar, PDUFA calendar, Historical FDA calendar and Company & CEO screener.

BPC is currently offering a discounted Elite subscription rate as part of its Annual Sale. To register for a free or paid account, visit https://www.biopharmcatalyst.com/sign-up?source=landiing. For more information on API access, email contact@biopharmcatalyst.com.

About Scientist.com

BioPharmCatalyst is a division of Scientist.com, the biopharma industry’s largest marketplace for R&D services. The company’s digital research platform enables biopharma researchers to carry out more innovative experiments in less time and at lower cost. Scientist.com connects the world’s top pharmaceutical companies, biotechnology companies and the US National Institutes of Health (NIH) to the world’s largest network of scientific suppliers.

Share article on social media or email:

Men, women, and even children can experience hair loss. It can be emotionally difficult to lose hair, whether temporary or permanent.

FORT LAUDERDALE, Fla. (PRWEB)
May 18, 2023

The TV series Empowered with Meg Ryan highlights hair loss causes and treatments in an upcoming program. The episode will share advanced innovations in hair loss and expert insight.

Empowered is an educational documentary series shedding light on significant stories impacting consumers worldwide.

Producers from Empowered with Meg Ryan collaborated with relevant groups specializing in hair loss to secure content for the program.

Some hair loss is typical, with most individuals losing some hair daily as part of a normal hair growth cycle. It’s average for a healthy person to lose around 100 strands of hair a day. Usually, hair loss grows back, and people can maintain a full head of hair. However, various illnesses, stress, hormonal changes, aging, tight hairstyles, perms or bleaching, and inherited conditions can affect a hair growth cycle. These conditions can cause hair to fall but prevent it from growing back.

Men, women, and even children can experience hair loss. It can be emotionally difficult to lose hair, whether temporary or permanent. Hair can significantly impact one’s self-esteem.

The most typical types of hair loss are Androgenic alopecia, Alopecia areata, Telogen effluvium, and Anagen effluvium. Treatment plans can vary, including medication, hair transplants, or platelet-rich plasma.

Segments of Empowered are developed through a quality-controlled and collaborative creative process. The Empowered team of creators utilizes their cumulative decades of experience to create unique and informational content. The Empowered program is developed for educational purposes and is made for distribution for multiple networks. Each episode is created using advanced filming techniques and technologies.

Share article on social media or email: